Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4112644 | 0.79 | — | — | |
| SCHEMBL5096643 | 0.79 | HDAC4 (0.33) | CES2CES1 | |
| SCHEMBL27588800 | 0.79 | CES2 (0.45) | CES2CES1 | |
| SCHEMBL27826253 | 0.78 | CES2 (0.41) | CES2CES1 | |
| SCHEMBL1600457 | 0.78 | CES2 (0.44) | CES2CES1 | |
| SCHEMBL5089366 | 0.76 | HPGD (0.31) | — | |
| SCHEMBL28974571 | 0.75 | CES2 (0.42) | CES2CES1 | |
| SCHEMBL1201506 | 0.75 | CES2 (0.52) | CES2CES1 | |
| SCHEMBL578144 | 0.75 | — | — | |
| SCHEMBL10779530 | 0.75 | CES2 (0.42) | CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1883619-B1 | PROCESS OF PREPARATION OF SUBSTITUTED TETRAFLUOROBENZYLANILINE COMPOUND AND ITS PHARMACEUTICALLY APPROVED SALTS | CHOONGWAE PHARMA CORP (KR) | 2013-03-20 | — | — | EP | disclosed |
| US-7495126-B2 | Process of preparation of substituted tetrafluorobenzylaniline compound and its pharmaceutically approved salts | CHOONGWAE PHARMA CORPORATION (KR) | 2009-02-24 | — | — | US | disclosed |
| US-20080167492-A1 | Process of Preparation of Substituted Tetrafluorobenzylaniline Compound and Its Pharmaceutically Approved Salts | CHOONGWAE PHARMA CORPORATION (KR) | 2008-07-10 | — | — | US | disclosed |
| EP-1883619-A1 | PROCESS OF PREPARATION OF SUBSTITUTED TETRAFLUOROBENZYLANILINE COMPOUND AND ITS PHARMACEUTICALLY APPROVED SALTS | Choongwae Pharma Corporation (KR) | 2008-02-06 | — | — | EP | disclosed |
| WO-2006126846-A1 | PROCESS OF PREPARATION OF SUBSTITUTED TETRAFLUOROBENZYLANILINE COMPOUND AND ITS PHARMACEUTICALLY APPROVED SALTS | CHOONGWAE PHARMA CORPORATION (KR) | 2006-11-30 | — | — | WO | disclosed |
| US-20050192359-A1 | N-biphenylamides and fungicidal compositions containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-09-01 | — | — | US | disclosed |
| EP-1486483-A1 | N-BIPHENYLAMIDES AND FUNGICIDAL COMPOSITIONS CONTAINING THE SAME | Sumitomo Chemical Company, Limited (JP) | 2004-12-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050192359-A1 | N-biphenylamides and fungicidal compositions containing the same | CBR3, ARNT, CBR1 | CES2 1280/4885CES1 1297/4885 |
| US-20080167492-A1 | Process of Preparation of Substituted Tetrafluorobenzylaniline Compound and Its Pharmaceutically Approved Salts | IL5, CYP3A5, PGA5 | CES2 3381/4885CES1 4330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.